---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-25-001136"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:23:30.542342+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Tonix promotes Siobhan Fogarty to Chief Technical Officer; PDUFA date Aug 15, 2025

## Summary
- Siobhan Fogarty appointed CTO effective February 3, 2025; annual salary of €385,000.
- Fogarty previously served as EVP Product Development since February 2021 and joined Tonix in 2016.
- FDA PDUFA goal date for TNX-102 SL (fibromyalgia) remains August 15, 2025; NDA submitted.
- Company preparing for potential launch of TNX-102 SL for management of fibromyalgia.

## SEC filing metadata
- accession: 0001999371-25-001136
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937125001136/0001999371-25-001136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937125001136/tnxp_8k-020425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-25-001136
- JSON: https://secwatch.observer/filing/0001999371-25-001136.json
- Plain text: https://secwatch.observer/filing/0001999371-25-001136.txt

## Key facts
- Executive change
  Siobhan Fogarty was appointed as Chief Technology Officer at Tonix Pharmaceuticals Holding Corp..
  - Action: appointed
  - Role: Chief Technology Officer
  source text: appointed Siobhan Fogarty as the Company’s Chief Technology Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000199937125001136/0001999371-25-001136-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.